Evidence map›Paper›PMID 26066891›Full record

ArticleThe Journal of investigative dermatology2015

EDA Fibronectin in Keloids Create a Vicious Cycle of Fibrotic Tumor Formation.

Rhiannon M Kelsh, Paula J McKeown-Longo, Richard A F Clark

Abstract readComment
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Shaping Oncogenic Microenvironments: Contribution of Fibronectin.Frontiers in cell and developmental biology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Cryptic activity within the Type IIICurrent topics in peptide & protein research
    Article
  20. Fibronectin Mechanobiology Regulates Tumorigenesis.Cellular and molecular bioengineering
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rhiannon M KelshCenter for Cell Biology & Cancer Research, Albany Medical College, Albany, New York, USA.
Paula J McKeown-LongoCenter for Cell Biology & Cancer Research, Albany Medical College, Albany, New York, USA. Electronic address: McKeowP@mail.amc.edu.
Richard A F ClarkDepartments of Dermatology and Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA. Electronic address: richard.clark@sunysb.edu.
Albany Medical Center Hospital · USStony Brook University · US

Funding

VITRONECTIN--STRUCTURE/FUNCTIONR01CA058626 · NCI · ALBANY MEDICAL COLLEGE · PI MC KEOWN-LONGO, PAULA J · 1993 to 2012
$3.3M
Regulation of Fibronectin Matrix Assembly by uPARR56CA058626 · NCI · ALBANY MEDICAL COLLEGE · PI MC KEOWN-LONGO, PAULA J · 2007 to 2007
$242k
NCI NIH HHS CA058626
6 · The paper itself

Abstract

During the early phase of wound healing, first plasma fibronectin (FN) and then in situ FN are deposited at the site of injury. In situ FN--FN made by tissue cells at the injury site--often contains an extra domain A (EDA) insert. Multiple wound-related signal transduction pathways control the deposition of EDA FN, and the EDA insert can in turn trigger pathways that induce inflammation, increased extracellular matrix molecule deposition including FN and collagen, and activation of fibroblasts. Together these pathways can create a vicious cycle that leads to fibrosis or keloid formation.

Indexed as

Gene Expression RegulationAnimalsEctodysplasinsFibroblastsFibronectinsHumansKeloidEctodysplasinsFibronectins

Identifiers

PMID26066891
OpenAlexW649361652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.